• Blog
  • Pricing
  • Contact
  • FAQ
Sign InSign Up
AI Agent for Financial MarketsAsk anything. Our AI Agent brings real-time data and full market coverage.Open chat
MarketsStocksCryptoForexCommoditiesCalendarInsiders
MDRX

MDRX

Veradigm Inc.

OTCHealthcareMedical - Healthcare Information ServicesUS

USD4.75

+0.25 (+5.56%)

Company Profile

CEO

Donald D. Trigg

IPO Date

1999-07-26

Sector

Healthcare

Industry

Medical - Healthcare Information Services

Exchange

OTC

Country

US

Market Metrics

Open

$4.62

Prev. Close

$4.50

Day Low

$4.61

Day High

$4.90

52W Low

$3.00

52W High

$6.00

Market Cap

$0.81B

Volume

0.00M

OverviewFinancialsRatingsInsidersSentimentsChart Patterns
News SentimentBullish

Articles

10

Avg Positive

47.7%

Avg Negative

2.0%

Avg Neutral

50.4%

News Feed

Allscripts to Release Second-Quarter 2021 Financial Results August 5

Business Wire·7/22/2021·↓ negative

Allscripts' (MDRX) Unit Inks Deal to Boost Clinical Research

Zacks Investment Research·6/25/2021·↑ positive

Leigh Burchell, Allscripts Vice President, Policy and Government Affairs, receives HIMSS21 Most Influential Women in Health IT Award

Business Wire·6/14/2021
·↑ positive

Allscripts Announces New Share Repurchase Program

Business Wire·5/26/2021·↑ positive

Veradigm Announces Collaboration With Lash Group to Streamline Patient Care

Business Wire·5/25/2021·↑ positive

US Orthopedic Alliance Selects 2bPrecise to Accelerate Precision Medicine Program

Business Wire·5/24/2021·↑ positive

SHAREHOLDER ALERT: Levi & Korsinsky, LLP Notifies Shareholders of an Investigation Concerning Possible Breaches of Fiduciary Duty by Certain Officers and Directors of Allscripts Healthcare Solutions, Inc.- MDRX

Newsfile Corp·5/14/2021·↓ negative

Blessing Health System Strengthens Its Allscripts Strategic Partnership

Business Wire·5/13/2021·↑ positive

Allscripts to Present at the 2021 Bank of America Health Care Conference

Business Wire·5/10/2021·↑ positive

Allscripts (MDRX) Inches Up 0.3% on Earnings Beat in Q1

Zacks Investment Research·5/5/2021·↑ positive